EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biocompatibility and Drug Release Properties of Carboxymethyl Cellulose Hydrogel for Carboplatin Delivery

Hiroyuki Kono iD, Shion Kinjyo, Ryou Uyama, Sayaka Fujita, Yuko Murayama, Shinya Ikematsu

Gels · 20.12.2025 · 12 (1) · 5

DOI: 10.3390/gels12010005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gels, online erschienen am 20.12.2025. Verfasst von Hiroyuki Kono und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Applied chemistry and Biochemistry, National Institute of Technology, Tomakomai College, Nishikioka 443, Tomakomai 059-1275, Japan. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Science and Technology Agency, JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE (JSPS) KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carboxymethylcellulose (CMC) is a biocompatible and biodegradable polysaccharide suitable for biomedical applications. Herein, an epichlorohydrin (ECH)-crosslinked CMC hydrogel (CMCG) was developed as a carrier for sustained drug release. Ether-type crosslinking between the hydroxyl groups of CMC and ECH yielded a transparent, highly water-absorbent gel. Structural analyses employing Fourier-transform infrared and solid-state 13C nuclear magnetic resonance spectroscopies confirmed successful crosslinking, and the hydrogel exhibited pH-dependent swelling. Carboplatin (CBP), a platinum-based anticancer drug, was incorporated into CMCG to prepare CBP-CMCG. In phosphate-buffered saline (pH 7.4), approximately 70% of CBP was released within 12 h, followed by a plateau phase, indicating diffusion-controlled release. Cytocompatibility assays using WI-38 normal human fibroblasts demonstrated that CMCG was non-cytotoxic, whereas free CBP induced significant cell death. In colorectal cancer HT-29 cells, CBP-CMCG exhibited gradual cytotoxicity, resulting in >80% nonviable cells after 24 h, indicating a sustained antitumor effect compared with free CBP. These results demonstrate that the newly developed ECH-crosslinked CMC hydrogel is a safe and effective platform for controlled drug delivery, enabling sustained release and prolonged therapeutic activity of CBP.

Schlagwörter

Stichwörter der Autor:innen

biocompatibilitycarboplatincarboxymethylcellulosecell culturecolorectal cancer cellscontrolled releasedrug delivery systemhydrogelin vivo studysafety evaluation

Autor:innen und Institutionen

  • Division of Applied chemistry and Biochemistry, National Institute of Technology, Tomakomai College, Nishikioka 443, Tomakomai 059-1275, Japan.
  • Department of Bioresources Engineering, National Institute of Technology, Okinawa College, Henoko 905, Nago 905-2192, Japan.

ORCID-Profile: Hiroyuki Kono

Förderung

  • Japan Society for the Promotion of Science
  • Japan Science and Technology Agency
  • JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE (JSPS) KAKENHI
  • Japan Science and Technology Agency (JST) SATREPS

Zitieren

APA

Kono, H., Kinjyo, S., Uyama, R., Fujita, S., Murayama, Y., & Ikematsu, S. (2025). Biocompatibility and Drug Release Properties of Carboxymethyl Cellulose Hydrogel for Carboplatin Delivery. Gels, 12(1), 5. https://doi.org/10.3390/gels12010005

Vancouver

Kono H, Kinjyo S, Uyama R, Fujita S, Murayama Y, Ikematsu S. Biocompatibility and Drug Release Properties of Carboxymethyl Cellulose Hydrogel for Carboplatin Delivery. Gels. 2025;12(1):5. doi:10.3390/gels12010005

BibTeX
@article{Kono2025,
  author = {Kono, Hiroyuki and Kinjyo, Shion and Uyama, Ryou and Fujita, Sayaka and Murayama, Yuko and Ikematsu, Shinya},
  title = {Biocompatibility and Drug Release Properties of Carboxymethyl Cellulose Hydrogel for Carboplatin Delivery},
  journal = {Gels},
  year = {2025},
  volume = {12},
  number = {1},
  pages = {5},
  doi = {10.3390/gels12010005}
}
Kostenlos starten →